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Today, to replace the antibacterial targets to overcome antibiotic resistance,
toxin–antitoxin (TA) system is noticeable, where the unstable antitoxin neutralizes the
stable toxin and protects the bacteria against the toxic effects. The presence and
expression of TA genes in clinical and non-clinical strains of Staphylococcus
epidermidis were investigated in this study. After identiﬁcation of three TA pairs
(mazEF, sam, and phd-doc) via existing databases (earlier, there has been no
information in the case of S. epidermidis isolates), the presence and expression of
these pairs were investigated by PCR and q-PCR, respectively. We detected three TA
modules in all antibiotic sensitive and resistant isolates. In addition, q-PCR analysis
revealed that the transcripts were produced from the three TA modules. This study
showed the signiﬁcant prevalence of these systems in pathogenic bacteria and they
were equally found in both oxacillin-resistant and oxacillin-susceptible bacteria. The
high prevalence of three systems can make them suitable as potential targets for
antibiotic therapy.
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Introduction
Toxin–antitoxin (TA) systems are small, bicistronic genetic elements that
are found on plasmids or chromosomes of bacteria. These systems have two parts:
a stable part called toxin protein that targets an essential cellular process and an
unstable part called antitoxin that acts as a direct inhibitor or controls toxin
production [1–4].
TA loci are often associated with pathogenic bacteria and most of them have
been found on plasmids containing antibiotic resistance genes [5].
The ﬁrst TA system was discovered in Escherichia coli. Over the years, TA
systems have been identiﬁed in many bacteria. Nowadays, based on the mode of
action and types of the antitoxin (can be a protein or RNA but toxins are always
proteins), six different types of TA systems have been identiﬁed. In type I systems,
the antitoxin suppresses the activity of the toxin protein by binding to mRNA
toxin. In types II and III, protein antitoxins and the RNA antitoxin directly bind to
the toxin proteins and block the activity of toxin proteins, respectively. In type IV,
antitoxin protein prevents the activity of the toxin by binding to its substrate. Type
V, identiﬁed as an endoribonuclease, cuts the toxin mRNA speciﬁcally. Type VI,
which is the last-type antitoxin molecules, acts as a proteolytic adapter, promoting
the degradation of the toxin protein [2, 6–8]. Importantly, these systems have not
only been reported to be associated with bacterial persistence but also have been
reported to have roles in bioﬁlm formation. These systems are proposed to be
considered as novel bacterial targets for antimicrobial therapy in pathogenic
bacteria [9].
One of the pathogenic bacteria that has a role in nosocomial infections is
S. epidermidis. This bacterium, as a member of human skin ﬂora [10], parti-
cipates in wide spectrum of infections by residing in medical devices [10, 11].
Unfortunately, in recent decades, antibiotic consumption in hospital wards
and development of different resistance mechanisms in S. epidermidis have
led to the situation of emergence as limited number of antibacterial agents
(e.g., vancomycin and linezolid) are available for treatment in severe hospital-
acquired infections [12].
If one of these TA systems is identiﬁed in all pathogenic clinical
strains, the TA systems would be a good target for antibiotic therapy for
pathogenic bacteria. For example, small molecules could be used to inter-
rupt the TA system interaction that would free the toxin to kill the host
cell [13–15].
Therefore, it is necessary to study the prevalence of TA systems and evaluate
the TA systems as new targets in clinical pathogenic S. epidermidis.
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Methods and Methods
Bacterial isolates and identiﬁcation
In total, 107 S. epidermidis isolates obtained from clinical [including blood
(n= 32), wound (n= 17), human ﬂora (n= 28), and urine (n= 24)], and
non-clinical samples [collected from laboratory environment (n= 6)] (Table I)
were collected during 5-month period from different hospitals and laboratories in
Tehran, Iran. The strains were identiﬁed as S. epidermidis by standard laboratory
tests, such as catalase, coagulase tests, resistance to polymyxin B and bacitracin
disks, sensitivity to novobiocin disk, and mannitol fermentation test.
Antimicrobial susceptibility testing
Susceptibility to six antibacterial agents including vancomycin (30 μg),
cefoxitin (30 μg) (as marker to detect of methicillin resistance or oxacillin
resistance), linezolid (30 μg), tetracycline (30 μg), erythromycin (15 μg), and
clindamycin (2 μg) was determined by disk diffusion method as CLSI guideline.
Staphylococcus aureus strain ATCC 25923 used for quality control of disk
diffusion method [16].
Identiﬁcation of TA genes in S. epidermidis
To ﬁnd TA genes in S. epidermidis, we obtained the complete genome of
S. epidermidis ATCC 12228 and S. epidermidis isolate BPH0662 from NCBI and
via different databases [17, 18] and wemanaged to ﬁnd the common TA loci (type II)
in these bacteria (mazEF, sam, and phd-doc) (Figure 1). Finally, speciﬁc primers
were designed using oligo software version 7.56 (Table II) [19].
Table I. The source of S. epidermidis isolates
Sources of
isolates Isolates
Number of
isolates
Wound 1–5, 8, 9, 23, 29–31, 34, 50, 77, 78, 97, 103 17
Blood 6, 10–12, 20, 22, 27, 28, 38, 39, 46, 48, 49, 52, 55–57, 61–63, 67, 68,
76, 79, 98–100
32
Urine 7, 15–19, 21, 24, 26, 37, 41, 47, 51, 58–60, 65, 66, 75, 80, 81, 94, 96,
95, 102
24
Flora 14, 101, 32, 33, 40, 42, 44, 53, 54, 64, 69–75, 82–90, 92, 93, 43 28
Environment 91, 13, 25, 35, 36, 45 6
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Table II. Characteristics of design primers and related genes used in the study
TA
system Sequence (5′→3′) TM
Amplicon
(bp)
Chromosome
locationa Reference
mazF
F CAAGGGGGAGTAAGACCTGT
58 95
1934159–
1934521
This
studyR TTAATCCTACCAGTAATCGCAGC
mazE
F GAAGGTTATGCACAAATGGC
56 83
1934518–
1934688
This
studyR TTGCAATCACAAGCTTCACA
doc
F GCTCAAAAGCACGCATTCCAT
60 110
1807207–
1807602
This
studyR ACCGCTTCATCTTGAGTGCAT
phd
F GCACTCGGAATATCAAATGGTG
57 93
1807602–
1807769
This
studyR AAACTCCTCGTCCTCTCTTAC
sam-T
F TTGCTCGTTGATGGAATGGCTT
61 181
1226550–
1227428
This
studyR GCCCCATATCCCAACAAACTGC
sam-AT
F GAAGTCAGCGCAGAAGCACAAT
61 231
1227447–
1230884
This
studyR AGTGGTCGCCTCATTAAGTCGT
Note: aOn S. epidermidis isolate BPH0662.
Figure 1. Genomic location of TA system in the chromosome of S. epidermidis isolate BPH0662
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Detection of TA genes in S. epidermidis isolates
PCR assay was used to depict the presence of TAmodules in the S. epidermidis
isolates. PCRwas performed in a DNA thermal cycler (Bio-Rad, USA) in a volume of
25 μl. The program consisted of an initial denaturation step at 94 °C for 4 min, 35×
94 °C for 30 s, annealing (annealing Tm for each primer is indicated in Table II) for
30 s, and extension at 72 °C for 20 s. No template control was used as negative
control. Finally, PCR products were sequenced (Macrogen, South Korea).
Quantitative real-time polymerase chain reaction
Bacteria were pelleted by centrifugation at 2,500 × g for 15 min. Total RNA
was isolated using the QIAGEN RNeasy Mini kit. Extracted RNA was analyzed
using a nanodrop ND1000 and running on a denaturing 1.5% Tris-acetate-EDTA-
agarose gels (80 V for 1 h) to assess RNA concentration, quality, and integrity.
The RNA was DNase treated with Promega RNase-free DNase (at 37 °C for 1 h).
RNA was precipitated with 1 volume isopropanol and 0.1 volume of 3 M NaOAc
(pH 4.6). The suspension was incubated on ice for 20 min and centrifuged at high
speed for 30 min at 4 °C. The RNA was pellet, dried, and resuspended with
RNase-free MilliQ H2O. According to the manufacturer’s instructions, 500 ng–
1 μg RNA was converted into cDNA using AccuPower CycleScript RT PreMix
(Bioneer, Korea). Quantitative real-time PCR was performed in a Rotor-Gene
thermal cycler (Corbett 6000, Australia) using SYBR Green method (AccuPower
Green Star qPCR Master Mix, Bioneer, Korea). A total volume of 20 μl reaction
containing 2 μl of cDNA, 12.5 μl SYBR Green master mix, 4.5 μl nuclease-free
water, and 1 μl of each primer (5 pmol) was run according to following program:
an initial activation step at 94 °C for 4 min, 35 cycles of denaturation at 94 °C for
30 s, annealing at (indicated in Table II) for 30 s, and extension at 72 °C for 20 s.
Statistical analysis
We used SPSS version 16 and chi-square program to assess the correlation
between the presence of TA genes and antibiotic-resistance pattern in S. epidermidis
isolates. A Pvalue ≤0.05 was considered as signiﬁcant.
Results
The antibiotic susceptibility pattern in all 107 S. epidermidis isolates showed
39.2%, 60.8%, 32%, 70.1%, 1%, and 1% resistance to clindamycin, methicillin,
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tetracycline, erythromycin, linezolid, and vancomycin, respectively. The highest
levels of resistance were seen to erythromycin and oxacillin, 70.1% (n= 68) and
60.8% (n= 59), respectively. The highest and lowest resistance to methicillin were
observed in blood (79.3%), environmental (77.8%), urine (72%), wound (60%),
and human ﬂora isolates (20.8%).
Surprisingly, urine, blood, and environmental isolates also had the highest
resistance to erythromycin (84%, 79.3%, and 77.8%, respectively) and the highest
sensitivity was seen in human ﬂora isolates (58.3%).
Fortunately, all isolates were sensitive to linezolid and vancomycin except
one vancomycin-resistant blood isolate and one linezolid-resistant environmental
isolate.
The highest resistance to tetracycline and clindamycin was shown in wound
isolates, whereas the highest sensitivity was seen in human ﬂora isolates (in both
antibiotics) and blood isolates (on the subject of tetracycline).
An attractive observation was the prevalence of three TA genes in
these isolates (Figure 2). Notably, mazEF, sam, and phd-doc loci were presented
in all 107 S. epidermidis isolates. These results demonstrated that there is no
difference between clinical and non-clinical and also resistant and sensitive isolates
to antibiotics in presence of TA genes. Given to qPCR results, it could be concluded
that the identiﬁed genes are transcriptionally activated and might be translated to the
proteins or functionally active RNAs in the different strains of S. epidermidis.
Discussion
Nowadays, the consumption of common antibiotics in treatment of
S. epidermidis infections has enhanced emergence of resistant isolates and has
increased use of glycopeptide antibiotics (vancomycin). The high rate of resistance
to methicillin (60.8%) was despairing, but the sensitivity of majority of the isolates
(99%) to vancomycin and linezolid is promising. Therefore, vancomycin can be
the best choice for S. epidermidis infections. Since, the rate of resistance to
vancomycin is increasing, to meet this problem (one blood isolate in this study)
and to ﬁnd the new antibacterial targets that can be useful in treatment. TA system
can be introduced as an antibacterial target [20]. The distribution of TA loci in
different species is shown according to the analyses in databases and studies of
prokaryotic genome [20].
However, there have been few studies about the existence and performance
of TA loci in different bacterial species. Current studies on TA systems showed the
possible roles of this system in antibiotic tolerance, bioﬁlm formation, niche
colonization, persistence, cell programmed death, chronic infections, and patho-
genicity [21–26].
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S. epidermidis is one of the common bioﬁlm-producing bacteria and the
cause of related infections [27]. Therefore, it is important to study factors involved
in bioﬁlm formation and increased tolerance to antibiotics in this bacteria as an
important pathogen. As different types of TA systems have roles in bioﬁlm
formation, pathogenesis, and tolerance to antibiotics, and there have been no
studies or analyses on these bacteria, it is important to study the prevalence and
existence of these systems in this pathogenic bacteria.
Type II system is the most common among TA systems according to
previous studies [28].
MazEF is one of the major groups of type II systems, which today is
considered as one of the important TA systems in bioﬁlm formation and
tolerance to antibiotics [29]. PCR and qPCR used in this study showed that the
prevalence of these systems in pathogenic bacteria is signiﬁcant and found in
both oxacillin-resistant and oxacillin-sensitive bacteria equally. The results
showed that all the oxacillin-resistant and oxacillin-sensitive bacteria in this
Figure 2. PCR detection of TA genes. Lane1, mazE; lane2, mazF; lane3, samT; lane4, samAT;
lane5, ladder; lane6, negative control; lane7, doc; lane8, phd. (T: toxin, AT: antitoxin)
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study had maz TA system with the prevalence of 100%. A similar prevalence of
this TA system was reported by Jain et al. [29]. They studied 101 MRSA strains
and reported that 100% of bioﬁlm-forming MRSAs had mazEF gene. Their
study shows the same prevalence of this TA system as this study. Another
study was conducted on the plasmid of 75 vancomycin-resistant enterococci
(VRE) samples by Moritz and Hergenrother [30] and same results were
reported. They showed in a study that all the plasmids had maz TA system.
Maz system was mostly on the plasmid containing vanA gene. With the results
of their study and high prevalence of mazEF in VRE plasmid, mazEF is
expected to be found on plasmids of similar species, such as staphylococci and
streptococci.
Phd-doc is another important type II TA system. This system is derived from
P1 bacteriophage and is involved in stress responses, plasmid stability resistance,
and essential performances, such as pathogenicity [31, 32]. The results of this
study, using PCR and real-time PCR, were the same as the results of maz TA and
all the S. epidermidis strains resistant and sensitive to oxacillin had this system and
also same prevalence of this system was observed in oxacillin-resistant and
oxacillin-sensitive strains.
It is also noteworthy that there are no evidences about sam gene in other
bacteria so far.
As this bacterium is known as a problem in hospitals for its ability to form
bioﬁlms and high prevalence and antibiotic resistance, ﬁnding new approaches to
ﬁght against pathogens is considered a worldwide priority in healthcare system.
Therefore, if one of these TA systems is found in all clinical species, it could be a
suitable target for antibiotic therapy.
In this study, which was based on PCR and qPCR techniques, all three TA
systems including mazEF, sam, and phd-doc were found in all 107 S. epidermidis
isolates. The high prevalence of these three systems can make them suitable targets
for antibiotic therapy.
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